Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 27,345 |
|
|||||
| News | - | ||||||
| Day High | 20.88 | Low High |
|||||
| Day Low | 20.315 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Prothena Corporation PLC | PRTA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.075 | -0.36% | 20.485 | 10:15:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 20.62 | 20.315 | 20.88 | 20.56 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 474 | 27,345 | $ 20.55 | $ 562,013 | - | 20.315 - 79.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:15:35 | 1 | $ 20.4814 | USD |
Prothena Corporation PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.11B | 53.72M | - | 91.37M | -147.03M | -2.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Prothena News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRTA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.61 | 21.79 | 20.315 | 20.90 | 475,832 | -1.13 | -5.21% |
| 1 Month | 25.07 | 26.36 | 20.315 | 23.04 | 550,933 | -4.59 | -18.29% |
| 3 Months | 29.98 | 31.03 | 20.315 | 26.09 | 658,788 | -9.50 | -31.67% |
| 6 Months | 42.98 | 43.285 | 20.315 | 32.05 | 781,506 | -22.50 | -52.34% |
| 1 Year | 54.97 | 79.65 | 20.315 | 42.88 | 623,470 | -34.49 | -62.73% |
| 3 Years | 23.90 | 79.749 | 20.315 | 45.32 | 527,881 | -3.42 | -14.29% |
| 5 Years | 11.15 | 79.749 | 6.44 | 37.02 | 425,673 | 9.34 | 83.72% |
Prothena Description
| Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). |
